| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c2480c33db6c462c626fe72c8750335b |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D243-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D243-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496 |
| filingDate |
2017-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce1ed467c229a0e08e9a3f846871a410
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb642c71d4e7bc3ab018c777a9385386
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d75e8f229e06d725fc07dcd33906e0c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f54e67a1c215ffdc2953cbb9d4066d52 |
| publicationDate |
2017-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2017214359-A1 |
| titleOfInvention |
Novel clostridium difficile toxin inhibitors |
| abstract |
The present invention relates to benzodiazepine derivative compounds of formula (I), or pharmaceutically acceptable salts thereof. The present benzodiazepine compounds are useful Clostridium difficile inhibitors in the treatment of Clostridium difficile infection in humans. The present invention provides a pharmaceutical composition containing benzodiazepine compounds of formula (I) and a method of making as well as a method of using the same in treating patients infected with Clostridium difficile infection by administering the same. The compounds of the present invention may be used in combination with additional antibiotics or anti-toxin antibody drugs. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022187178-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11434249-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3606519-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021208945-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018187506-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2018250217-B2 |
| priorityDate |
2016-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |